• Wrong document? Swap it for free
  • Written by students who passed
  • Immediately available after payment
  • Read online or as PDF
Sell
Where do you study
Your language
Document preview thumbnail
Preview 4 out of 107 pages
Exam (elaborations)

TEST BANK - Pharmacotherapeutics for Advanced Practice Nurse Prescribers

Document preview thumbnail
Preview 4 out of 107 pages

TEST BANK - Pharmacotherapeutics for Advanced Practice Nurse Prescribers Questions 1–180 | Advanced Pharmacology for APRNs | 100% Pass Guaranteed | Graded A+

Content preview

1



TEST BANK - Pharmacotherapeutics for
Advanced Practice Nurse Prescribers
Questions 1–180 | Advanced Pharmacology for APRNs | 100% Pass Guaranteed
| Graded A+



1. A patient asks the APRN why they must take a medication every day even
after they feel better. The APRN's best response is based on the concept
of:

A. Bioavailability
B. Steady state
C. Half-life
D. Protein binding

ANS : B
Explanation: Steady state is achieved when the amount of drug administered
equals the amount of drug eliminated, maintaining a relatively constant drug
level in the body. This typically requires consistent dosing for four to five half-
lives and is necessary to maintain therapeutic efficacy even when symptoms
have improved.



2. An APRN is prescribing a drug that is a receptor agonist. Which of the
following effects is most likely to occur with continuous, long-term use of
this medication?
1

, 2



A. Upregulation of the receptor
B. Downregulation of the receptor
C. No change in receptor number
D. Increased sensitivity to the drug

ANS : B
Explanation: Continuous stimulation of a receptor by an agonist can lead to
receptor desensitization or downregulation, where the body decreases the
number of receptors available. This can result in tolerance and the need for
higher doses to achieve the same effect .



3. A patient abruptly stops taking a beta-blocker and experiences rebound
tachycardia. This is most likely due to which of the following
pharmacologic phenomena?

A. Downregulation of receptors
B. Upregulation of receptors
C. First-pass effect
D. Drug antagonism

ANS : B
Explanation: Chronic use of a receptor antagonist such as a beta-blocker can
lead to upregulation (increased receptor number). When the antagonist is
abruptly withdrawn, these excess receptors are exposed to endogenous
agonists, leading to an exaggerated response. This is why beta-blockers should
be tapered .

2

, 3




4. A drug administered via the IV route begins distribution into the body:

A. After it is absorbed in the GI tract
B. Immediately after administration
C. After binding to plasma proteins
D. After passing through the liver

ANS : B
Explanation: IV administration delivers the drug directly into the bloodstream,
bypassing absorption. Distribution begins immediately as the drug is carried by
the circulatory system to tissues and organs. Other routes, such as oral, require
absorption before distribution can occur .



5. When combining two drugs that have a synergistic effect, the combined
effect is:

A. The sum of each drug's individual effects
B. Greater than the sum of each drug's individual effects
C. Less than the effect of each drug alone
D. Unpredictable and varies with each individual

ANS : B
Explanation: Synergy occurs when the combined effect of two drugs is greater
than the sum of their individual effects. This is a desired effect in some



3

, 4



therapeutic regimens but requires careful dosing to avoid toxicity. Additive
effect (A) is the simple sum of individual effects .



6. An APRN is prescribing a drug with a narrow therapeutic range. Which of
the following factors related to bioavailability is most important to
consider?

A. The drug's half-life
B. The drug's protein-binding capacity
C. Consistency between different brands of the drug
D. The drug's route of administration

ANS : C
Explanation: For drugs with narrow therapeutic ranges, small variations in
bioavailability between different brands or formulations can lead to toxicity or
therapeutic failure. Consistency in bioavailability is critical, and these drugs
should ideally be prescribed by brand name to ensure the patient receives the
same formulation each time .



7. A patient is prescribed a sustained-release medication. The patient asks if
they can crush the tablet to make it easier to swallow. The APRN's best
response is:

A. "Yes, crushing it will not affect how the drug works."
B. "No, crushing may lead to toxicity from a rapid release of the entire dose."


4

Document information

Uploaded on
September 4, 2026
Number of pages
107
Written in
2026/2027
Type
Exam (elaborations)
Contains
Questions & answers
$15.99

Wrong document? Swap it for free Within 14 days of purchase and before downloading, you can choose a different document. You can simply spend the amount again.
Written by students who passed
Immediately available after payment
Read online or as PDF

Sold
1
Followers
0
Items
173
Last sold
4 days ago



Why students choose Stuvia

Created by fellow students, verified by reviews

Quality you can trust: written by students who passed their tests and reviewed by others who've used these notes.

Didn't get what you expected? Choose another document

No worries! You can instantly pick a different document that better fits what you're looking for.

Pay as you like, start learning right away

No subscription, no commitments. Pay the way you're used to via credit card and download your PDF document instantly.

Student with book image

“Bought, downloaded, and aced it. It really can be that simple.”

Alisha Student

Working on your references?

Create accurate citations in APA, MLA and Harvard with our free citation generator.

Working on your references?

Frequently asked questions